Vascular calcification: Good, bad or ugly?

Vascular Medicine

Volumn 7, Issue 3, 2002, Pages 161-162

  Mohler III, Emile R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTILIPEMIC AGENT; BONE MORPHOGENETIC PROTEIN; CALCIUM; LIPID; OSTEONECTIN; OSTEOPONTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; AORTA VALVE DISEASE; ARTERY CALCIFICATION; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CORONARY ARTERY; DRUG EFFECT; EDITORIAL; ELECTRON BEAM TOMOGRAPHY; HUMAN; ISOLATED HEART; LIPID OXIDATION; MOLECULAR DYNAMICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL;

CALCINOSIS; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; VASCULAR DISEASES;

EID: 0036961453     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x02vm442ed     Document Type: Editorial

References (19)

1. McMillan GC. Historical review of research on atherosclerosis. Adv Exp Med Biol 1995; 369: 1-6.
2. Bostrom K, Watson KE, Horn S, Lam T, Norton B, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1994; 91: 1800-809.
3. Watson KE, Bostrom K, Ravindranath R et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994; 93: 2106-13.
4. Parhami F, Morrow AD, Balucan J et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680-87.
5. Mohler ER, Chawla MK, Chang AW et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999; 8: 254-60.
6. O'Brien ER, Garvin MR, Stewart DK et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994; 14: 1648-56.
7. Mohler ER, Adam LP, McClelland P et al. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997; 17: 547-52.
8. Mohler ER, Gannon FH, Reynolds C et al. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-28.
9. O'Brien KD, Kuusisto J, Reichenbach DD et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92: 2163-68.
10. Otto CM, Kuusisto J, Reichenbach DD et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: Histological and immunohistochemical studies. Circulation 1994; 90: 844-53.
11. Mohler ER III. Are atherosclerotic processes involved in aortic-valve calcification? Lancet 2000; 356: 524-25.
12. Hunt JL, Fairman R, Mitchell ME et al. Bone formation in carotid plaques: A clinicopathological study. Stroke 2002; 33: 1214-19.
13. Johnson JM, Kennelly MM, Decesare D et al. Natural history of asymptomatic carotid plaque. Arch Surg 1985; 120: 1010-12.
14. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: The TROMSO study. Circulation 2001; 103: 2171-75.
15. Gronholdt MLM, Nordestgaard BG, Schroeder TV et al. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68-73.
16. Cohen A, Tzourio C, Bertrand B et al. Aortic plaque morphology and vascular events: A follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997; 96: 3838-41.
17. Mintz GS, Pichard AD, Popma JJ et al. Determinants and correlates of target lesion calcium in coronary artery disease: A clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol 1997; 29: 268-74.
18. Beckman JA, Ganz J, Creager MA et al. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 2001; 21: 1618-22.
19. Callister TQ, Raggi P, Cooli B et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998; 339: 1972-78.